The effectiveness of varicella vaccine in China

Pediatric Infectious Disease Journal

Volumn 29, Issue 8, 2010, Pages 690-693

  Fu, Chuanxi ^a   Wang, Ming ^a   Liang, Jianhua ^a   Xu, Jianxiong ^a   Wang, Chengbin ^b   Bialek, Stephanie ^b  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

chickenpox; vaccine effectiveness; waning immunity

Indexed keywords

VARICELLA ZOSTER VACCINE; CHICKENPOX VACCINE;

ARTICLE; CASE CONTROL STUDY; CHICKENPOX; CHILD; CHINA; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INTERVIEW; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; FEMALE; IMMUNOLOGY; INCIDENCE;

CASE-CONTROL STUDIES; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; INCIDENCE; MALE;

EID: 77955172108     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181d7380e     Document Type: Article

References (36)

1. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9:361-381.
2. Takahashi M, Otsuka T, Okuno Y, et al. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2:1288-1290.
3. Lu X, Zhou W, Gu K, et al. Evaluation on safety and immunogenicity of Changshengkeji Frozen-dried live attenuated varicella vaccine. J Southeast Univ. 2008;27:5.
4. Chiu SS, Lau YL. Review of the Varilrix varicella vaccine. Expert Rev Vaccines. 2005;4:629-643.
5. Wang L, Liu Y, Li L, et al. Observation on the immunity efficacy of Domestic Freeze-dried live attenuated varicella vaccine. South China J Prevent Med. 2003;29.
6. Wang S, Li C, Li Y, et al. Study on safety and immunogenicity of lyophilized live attenuated domestic varicella vaccine. Chin J Vaccines Immun. 2000;6:4.
7. Ndumbe PM, Cradock-Watson JE, Heath RB, et al. Live varicella immunization in healthy non-immune nurses. Postgrad Med J. 1985;61(suppl 4):133-135.
8. Kappagoda C, Shaw P, Burgess M, et al. Varicella vaccine in non-immune household contacts of children with cancer or leukaemia. J Paediatr Child Health. 1999;35:341-345.
9. Arvin AM. Varlirix (GlaxoSmithKline). Curr Opin Investig Drugs. 2002; 3:996-999.
10. Fu C, Wang M, Liang J, et al. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Vaccine. 2007;25:8756-8761.
11. Greenwood M, Yule G. The statistics of anti-typhoid and anti-cholera inoculations. Proc R Soc Med. 1915;8:113-194.
12. Niccolai LM, Ogden LG, Muehlenbein CE, et al. Methodological issues in design and analysis of a matched case-control study of a vaccine's effectiveness. J Clin Epidemiol. 2007;60:1127-1131.
13. Sheffer R, Segal D, Rahamani S, et al. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J. 2005;24:434-437.
14. Passwell JH, Hemo B, Levi Y, et al. Use of a computerized database to study the effectiveness of an attenuated varicella vaccine. Pediatr Infect Dis J. 2004;23:221-226.
15. Seward JF, Marin M, Vazquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis. 2008;197(suppl 2):S82-S89.
16. Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23:132-137.
17. Vessey SJ, Chan CY, Kuter BJ, et al. Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy. J Pediatr. 2001;139:297-304.
18. Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics. 1986;78:748-756.
19. Ozaki T, Nishimura N, Kajita Y. Experience with live attenuated Varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic. Vaccine. 2000;18:2375-2380.
20. Arvin AM. Cell-mediated immunity to Varicella-zoster virus. J Infect Dis. 1992;166(suppl 1):S35-S41.
21. Li S, Chan IS, Matthews H, et al. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr Infect Dis J. 2002;21:337-342.
22. Watson B, Boardman C, Laufer D, et al. Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine. Clin Infect Dis. 1995;20:316-319.
23. Brisson M, Edmunds WJ, Gay NJ, et al. Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine. 2000;18:2775-2778.
24. Arvin AM. Immune responses to Varicella-zoster virus. Infect Dis Clin North Am. 1996;10:529-570.
25. Krause PR, Klinman DM. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nat Med. 2000;6:451-454.
26. Krause PR. Evidence for frequent reactivation of the Oka varicella vaccine strain in healthy vaccinees. Arch Virol Suppl. 2001:7-15.
27. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med. 2002;347:1909-1915.
28. Tugwell BD, Lee LE, Gillette H, et al. Chickenpox outbreak in a highly vaccinated school population. Pediatrics. 2004;113:455-459.
29. Lee BR, Feaver SL, Miller CA, et al. An elementary school outbreak of varicella attributed to vaccine failure: policy implications. J Infect Dis. 2004;190:477-483.
30. Chaves SS, Gargiullo P, Zhang JX, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007;356:1121-1129.
31. Vazquez M, LaRussa PS, Gershon AA, et al. Effectiveness over time of varicella vaccine. JAMA. 2004;291:851-855.
32. Lopez AS, Guris D, Zimmerman L, et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics. 2006;117:e1070-e1077.
33. Galil K, Fair E, Mountcastle N, et al. Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis. 2002;186:102-105.
34. Marin M, Nguyen HQ, Keen J, et al. Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003. Pediatrics. 2005; 115:900-905.
35. Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis. 2008; 197(suppl 2):S71-S75.
36. Jin L, Feng Z. Analysis of the epidemic situation of chicken pox from 2005 to 2006 in China. Dis Surveill. 2007;22:251-253.